Home・Aandelen Lijst・Vivani Medical

Vivani Medical

Gesloten

1.37 -2.14

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.3900000000000001

Max

1.41

Belangrijke statistieken
By Trading Economics
Inkomsten	-147K -6.8M
Werknemers	42

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+169.72% upside

Dividenden
By Acuity
Volgende Winsten	12 nov 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	22M 98M
Vorige openingsprijs	3.51
Vorige sluitingsprijs	1.37

Vivani Medical Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 aug 2026, 23:53 UTC

EUR/AUD is trading slightly higher in after-market hours, continuing its performance since Friday's close, though it remains near the lower end of its one-month range.

30 aug 2026, 23:53 UTC

Correlated Moves

Gold/AUD is lower amid cautious sentiment following Barclays' warning of a potential commodity shock due to adverse weather and underinvestment in production.

30 aug 2026, 23:53 UTC

Correlated Moves

Silver Ounce vs Euro is trading lower amid a broader decline in gold prices. Market sentiment is impacted by a Barclays report on potential commodity shocks.

30 aug 2026, 23:51 UTC

Correlated Moves

The S&P 500 Index is lower amid broader market trends and cautious investor sentiment following Barclays' forecasts of a potential commodity shock.

30 aug 2026, 23:51 UTC

Ethereum Drops 2.5% Amid Tech Stock Sell-Off and Economic Indicators, While Commodity Shock Looms from El Niño and Geopolitical Tensions Persist.

30 aug 2026, 23:51 UTC

Cryptocurrency Markets Decline Amid Geopolitical Tensions and Commodity Shock Warnings, with Key Economic Data Releases Ahead.

30 aug 2026, 23:51 UTC

Cryptocurrency markets decline as hedge funds sell tech stocks, while looming commodity shocks and geopolitical tensions raise inflation concerns ahead of key U.S. and Canadian labor data releases.

30 aug 2026, 23:51 UTC

Cryptocurrency markets decline as hedge funds sell tech stocks; Japan's economic indicators reveal consumer spending trends amid global uncertainties, while Barclays warns of a commodity shock from El Niño.

30 aug 2026, 23:51 UTC

Brazil's S&P Global Services PMI set for release on September 3, with analysts wary of further contraction following August's drop to 49.7 amid rising costs and political uncertainties.

30 aug 2026, 23:51 UTC

Australia's Building Permits Expected to Decline by 4.8% in July Amidst Economic Pressures and Market Volatility

30 aug 2026, 23:51 UTC

EUR/DKK remains effectively unchanged in after-market trading, showing unusual stability within a narrow band around its one-month trading range midpoint.

30 aug 2026, 23:51 UTC

Correlated Moves

Gold Ounce vs Euro is trading lower, continuing a five-session decline, influenced by falling Silver and cautious sentiment amid forecasts of a commodity shock.

30 aug 2026, 23:51 UTC

News

Bitcoin is trading lower today, despite earlier gains and social media discussions about Steak 'n Shake's Bitcoin initiative and potential AI investor interest.

30 aug 2026, 23:51 UTC

Bitcoin is trading lower during Sunday’s session amid heightened volatility. The price remains above its 20-day moving average and near its one-month range.

30 aug 2026, 23:42 UTC

Correlated Moves

The Nasdaq 100 Index is lower during Sunday’s session, reflecting broader market caution amid concerns over potential commodity shocks and adverse weather patterns.

30 aug 2026, 23:41 UTC

Japan's Industrial Production Expected to Decline in July Amid Global Economic Concerns and Commodity Supply Chain Disruptions.

30 aug 2026, 23:41 UTC

U.S. Unemployment Rate Release on September 4, 2026 Expected at 4.2%, Amid Cautious Optimism and Potential Fed Policy Implications

30 aug 2026, 23:41 UTC

US Average Hourly Earnings Expected to Rise 0.2% Amid Cautious Market Sentiment on Wage Growth and Inflation Concerns

30 aug 2026, 23:41 UTC

Labor Force Participation Rate in the U.S. Declines to 61.4%, Raising Concerns Ahead of September 2026 Data Release

30 aug 2026, 23:41 UTC

Investors Anticipate Key U.S. Average Hourly Earnings Data Amid Rising Inflation Concerns Ahead of September 4 Release

30 aug 2026, 23:41 UTC

US Non-Farm Payrolls Expected to Rise by Only 45K Jobs in August Amid Growing Employment Concerns

30 aug 2026, 23:41 UTC

Canada's Unemployment Rate Expected to Decrease Slightly to 6.4% Amidst Economic Challenges and Improved Employment Figures

30 aug 2026, 23:41 UTC

Canada's Labor Force Participation Rate Release on September 4, 2026, May Reflect Employment Dynamics Amid Housing Initiatives.

30 aug 2026, 23:41 UTC

Canada's Employment Change Forecast for August 2026 Predicts +15.8K Jobs Amid Positive Labor Market Sentiment Following July's Surprising Gain of +75.1K Positions

30 aug 2026, 23:41 UTC

Canada's Full-Time Employment Change Report Set for Release on September 4, Amid Economic Concerns and Political Developments.

30 aug 2026, 23:41 UTC

Canada's Part-Time Employment Change Report Set for September 4, 2026, Amid Cautious Optimism in Labor Market Dynamics.

30 aug 2026, 23:31 UTC

Correlated Moves

Avalanche is trading lower amid broader market sentiment, reflecting volatility. The asset remains above its 20-day moving average despite today's decline.

30 aug 2026, 23:31 UTC

Terra is trading lower today amid ongoing volatility and remains below its 20-day moving average, reflecting a decline since Saturday's session.

30 aug 2026, 23:31 UTC

Japan's Retail Sales Expected to Rise 0.03% YoY in July Amid Cautious Economic Sentiment and Weak Bond Market Performance

30 aug 2026, 23:31 UTC

Correlated Moves

XRP is declining during Sunday’s session amid notable volatility, aligning with a drop in Bitcoin. The asset remains above its 20-day moving average.

Peer Vergelijking

Prijswijziging

Vivani Medical Prognose

Koersdoel

By TipRanks

169.72% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 3.83 USD 169.72%

Hoogste 4 USD

Laagste 3.5 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Vivani Medical - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Vivani Medical - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Winst voor belastingen

Verkoop

Operationele winst

Over Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.